429 related articles for article (PubMed ID: 12121502)
1. Hepatorenal syndrome in patients with cirrhosis.
Moreau R
J Gastroenterol Hepatol; 2002 Jul; 17(7):739-47. PubMed ID: 12121502
[TBL] [Abstract][Full Text] [Related]
2. Hepatorenal syndrome: Current concepts related to diagnosis and management.
de Mattos ÁZ; de Mattos AA; Méndez-Sánchez N
Ann Hepatol; 2016; 15(4):474-81. PubMed ID: 27236146
[TBL] [Abstract][Full Text] [Related]
3. [Hepatorenal syndrome in decompensated cirrhosis : A special form of acute renal failure].
Lenz K; Buder R; Lohr G; Piringer P; Voglmayr M
Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):440-6. PubMed ID: 27241778
[TBL] [Abstract][Full Text] [Related]
4. [Hepatorenal syndrome: diagnosis, treatment and prevention].
Egerod Israelsen M; Gluud LL; Bendtsen F; Møller S; Krag AA
Ugeskr Laeger; 2013 May; 175(22):1562-6. PubMed ID: 23721840
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.
Salerno F; Gerbes A; Ginès P; Wong F; Arroyo V
Gut; 2007 Sep; 56(9):1310-8. PubMed ID: 17389705
[No Abstract] [Full Text] [Related]
6. Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis.
Colle I; Durand F; Pessione F; Rassiat E; Bernuau J; Barrière E; Lebrec D; Valla DC; Moreau R
J Gastroenterol Hepatol; 2002 Aug; 17(8):882-8. PubMed ID: 12164964
[TBL] [Abstract][Full Text] [Related]
7. Terlipressin in hepatorenal syndrome: Evidence for present indications.
Rajekar H; Chawla Y
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
[TBL] [Abstract][Full Text] [Related]
8. Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients.
Dagher L; Patch D; Marley R; Moore K; Burroughs A
Aliment Pharmacol Ther; 2000 May; 14(5):515-21. PubMed ID: 10792112
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in our understanding of hepatorenal syndrome.
Wong F
Nat Rev Gastroenterol Hepatol; 2012 May; 9(7):382-91. PubMed ID: 22614754
[TBL] [Abstract][Full Text] [Related]
10. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.
Neri S; Pulvirenti D; Malaguarnera M; Cosimo BM; Bertino G; Ignaccolo L; Siringo S; Castellino P
Dig Dis Sci; 2008 Mar; 53(3):830-5. PubMed ID: 17939047
[TBL] [Abstract][Full Text] [Related]
11. Hepatorenal Syndrome: Pathophysiology, Diagnosis, and Treatment.
Belcher JM
Med Clin North Am; 2023 Jul; 107(4):781-792. PubMed ID: 37258014
[TBL] [Abstract][Full Text] [Related]
12. Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome.
Testro AG; Angus PW
J Gastroenterol Hepatol; 2009 Nov; 24(11):1707-9. PubMed ID: 20136956
[No Abstract] [Full Text] [Related]
13. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
Boyer TD; Sanyal AJ; Wong F; Frederick RT; Lake JR; O'Leary JG; Ganger D; Jamil K; Pappas SC;
Gastroenterology; 2016 Jun; 150(7):1579-1589.e2. PubMed ID: 26896734
[TBL] [Abstract][Full Text] [Related]
14. Reversal of hepatorenal syndrome in cirrhotic patients with terlipressin plus albumin. First experience in Mexico.
Muñoz LE; Alcalá EG; Cordero P; Martínez MA; Vázquez NY; Galindo S; Mendoza E; Segura JJ
Ann Hepatol; 2009; 8(3):207-11. PubMed ID: 19841499
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the management of hepato-renal syndrome (HRS).
Fabrizi F; Martin P; Messa P
Acta Clin Belg; 2007; 62 Suppl 2():393-6. PubMed ID: 18284007
[TBL] [Abstract][Full Text] [Related]
16. [Hepatorenal syndrome - pathophysiology, diagnosis and treatment].
Hrabovský V; Mendlová A; Vavříčková T
Vnitr Lek; 2015; 61(7-8):649-54. PubMed ID: 26375691
[TBL] [Abstract][Full Text] [Related]
17. Review article: pharmacological treatment of hepatorenal syndrome.
Ginès P; Torre A; Terra C; Guevara M
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():57-62; discussion 63-4. PubMed ID: 15335404
[TBL] [Abstract][Full Text] [Related]
18. Hepatorenal syndrome. Long-term treatment with terlipressin as a bridge to liver transplantation.
Ganne-Carrié N; Hadengue A; Mathurin P; Durand F; Erlinger S; Benhamou JP
Dig Dis Sci; 1996 Jun; 41(6):1054-6. PubMed ID: 8654133
[TBL] [Abstract][Full Text] [Related]
19. Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study.
Halimi C; Bonnard P; Bernard B; Mathurin P; Mofredj A; di Martino V; Demontis R; Henry-Biabaud E; Fievet P; Opolon P; Poynard T; Cadranel JF
Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):153-8. PubMed ID: 11981339
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
Krag A; Borup T; Møller S; Bendtsen F
Adv Ther; 2008 Nov; 25(11):1105-40. PubMed ID: 19018483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
